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Abstract
Background: The association of right ventricular (RV) structure and function with symptoms in individuals without
cardiopulmonary disease is unknown. We hypothesized that greater RV mass and RV end-diastolic volume (RVEDV), smaller RV
stroke volume (RVSV), and lower RV ejection fraction (RVEF) measured by cardiac magnetic resonance imaging (MRI) in
participants free of clinical cardiovascular disease at baseline would be associated with a greater risk of self-reported dyspnea.
Methods: The Multi-Ethnic Study of Atherosclerosis (MESA) performed cardiac MRIs on participants without clinical
cardiovascular disease between 2000 and 2002. We excluded subjects who reported ‘‘prevalent’’ dyspnea at the first
assessment (24 months). The presence of dyspnea was assessed at 24 months, 42 months, and 60 months from baseline.
Cox proportional hazards models were used to examine the relationship between RV measures and incident dyspnea.
Results: In the final study sample (N = 2763), there were significant interactions between RV measures and sex in terms of
the risk of dyspnea (p,0.05). Among men (N= 1453), lower RV mass (p = 0.003), smaller RVEDV (p,0.001), smaller RV end-
systolic volume (RVESV) (p = 0.03) and decreased RVSV (p,0.001) were associated with an increased risk of developing
dyspnea after adjusting for covariates. Associations remained after adjusting for left ventricular function and lung function.
However, there were no significant associations between RV measures and the risk of dyspnea in women.
Conclusions: Lower RV mass and smaller RV volumes were associated with an increased risk of dyspnea in men, but not in
women.
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Introduction
While the importance of changes in left ventricular (LV)
structure and function is well-defined, our understanding of the
consequences of structural and functional changes in the RV is
quite limited by comparison. As two pumps in series, the LV
cardiac output (and systemic perfusion) is dependent on RV
function in both healthy individuals and those with disease.
Therefore, subclinical changes in RV morphology could herald
the onset of cardiopulmonary limitation, prior to detectable LV
changes or symptoms.
RV structure and function are associated with outcomes in
patients with cardiovascular disease [1], [2], [3], [4]. However,
there are no studies of the association of RV morphology with
symptoms in individuals without clinical cardiovascular disease.
An association of RV parameters in individuals without known
cardiovascular disease with subsequent activity-limiting dyspnea
could reflect either a direct contribution of RV function to
functional status or the impact of sub-clinical lung disease on the
RV. In either case, RV morphology could be an important
subclinical indicator of cardiopulmonary dysfunction. We hypoth-
esized that greater RV end-diastolic mass (RVEDM), larger RV
end-diastolic volume (RVEDV), smaller RV stroke volume
(RVSV), and lower RV ejection fraction (RVEF) at baseline,
due to increased RV afterload from underlying lung or heart
disease, would be associated with a greater risk of the development
of self-reported dyspnea.
Methods
The Multi-Ethnic Study of Atherosclerosis
The Multi-Ethnic Study of Atherosclerosis (MESA) is a
multicenter prospective cohort study to investigate the prevalence,
correlates and progression of subclinical cardiovascular disease in
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whites, African Americans, Hispanics, and Chinese [5]. In 2000–
2002, MESA recruited 6,814 men and women aged 45–84 years
old from six U.S. communities: Forsyth County, NC; Northern
Manhattan and the Bronx, NY; Baltimore City and Baltimore
County, MD; St. Paul, MN; Chicago, IL; and Los Angeles, CA.
Exclusion criteria included clinical cardiovascular disease (phy-
sician diagnosis of heart attack, stroke, transient ischemic attack,
heart failure, angina, current atrial fibrillation, any cardiovascular
procedure), weight .136 kg (300 lbs), pregnancy, or impediment
to long-term participation. The protocols of MESA and all
studies described herein were approved by the Institutional
Review Boards of all collaborating institutions (Columbia
University, New York; Johns Hopkins University, Baltimore;
Northwestern University, Chicago; University of California, Los
Angeles; University of Minnesota, Twin Cities; Wake Forrest
University, Winston-Salem) and the National Heart Lung and
Blood Institute. Written informed consent was obtained from all
participants.
The MESA-Right Ventricle Study is an ancillary study
supported by an NIH grant that planned for the interpretation
of approximately 4200 cardiac MRIs at the baseline examina-
tion (Exam 1) for measurement of RV morphology. We selected
4634 scans for RV interpretation, and 4484 had interpretation
attempted. We successfully interpreted scans of 4204 individuals
(94% of attempted). Participants were sampled without regard
to demographics, anthropometrics, or other clinical variables.
Since questionnaire data regarding dyspnea were not collected
at Exam 1, we included only those subjects who denied dyspnea
at Exam 2 to exclude those with prevalent dyspnea (see below)
(Figure 1).
Cardiac Magnetic Resonance Imaging Measures
The cardiac MRI protocol has been previously described [6].
All imaging was performed on 1.5 T magnets with a 4-element
phased-array surface coil positioned anteriorly and posteriorly and
electrocardiographic gating. Imaging consisted of fast gradient
echo cine images with temporal resolution #50 ms.
Methods for interpretation of LV and RV parameters have
been previously reported [7], [8]. Briefly, RV image analysis was
performed by two independent analysts on Windows workstations
using QMASS software (v4.2, Medis, the Netherlands). The
endocardial and epicardial borders of the RV were traced
manually on the short axis cine images at the end-systolic and
end-diastolic phase. RV end-systolic volume (RVESV) and
RVEDV were calculated using Simpson’s rule by summation of
areas on each slice multiplied by the sum of slice thickness and
image gap. RV mass was determined at the end-diastole phase as
the difference between end-diastolic epicardial and endocardial
volumes multiplied by the specific gravity of the heart (1.05 g/
cm3). RVSV was calculated by subtracting RVESV from the
RVEDV. RVEF was calculated by dividing RVSV by RVEDV.
The intra-reader intraclass coefficients (ICCs) for random, blinded
re-reads of 230 scans were 0.99 for RVEDV, 0.89 for RVEF and
0.94 for RV mass (N= 229). The inter-reader ICCs from random,
blinded re-reads of 240 scans for RV mass and RVEDV were 0.89
and 0.96 respectively and 0.80 for RVEF.
Dyspnea
The MESA medical history questionnaire was administered to
participants at Exams 2, 3, and 4 (approximately 24 months, 42
months, and 60 months, respectively, after the baseline exam and
cardiac imaging) and contained the following questions: ‘‘When
walking on level ground, do you get more breathless than people
Figure 1. Study sample.
doi:10.1371/journal.pone.0056826.g001
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your own age?’’ ‘‘When walking up hills or stairs, do you get more
breathless than people your own age?’’ ‘‘Do you ever have to stop
walking because of breathlessness?’’ The answer to each of these
questions was assessed independently. Time from Exam 2 to an
affirmative answer to any one of these three questions at Exam 3
or 4 (or death) was considered as the dependent variable. Death
was included because this event was likely informative, defying the
assumptions required for censoring in survival analysis.
Covariates
Race/ethnicity was self-reported during the baseline MESA
exam according to 2000 US Census criteria as race (Caucasian,
African-American, Chinese) and ethnicity (Hispanic or non-
Hispanic). Participants self-identifying as Hispanic were catego-
rized as Hispanic. Standard questionnaires were used to ascertain
smoking status (classified as never, former, or current) and pack
Table 1. Characteristics of study population.
Variable Value Male (N=1453) Female (N=1310) Study Sample (N=2763) Excluded (N=4051)
Age Mean +/2 SD 61.1+/210.0 61.5+/2 10.1 61.3+/210.0 62.7+/210.3
Sex Male 1,453 (52.6) 1,760 (43.4)
Race Caucasian 576 (39.6) 524 (40.0) 1,100 (39.8) 1,522 (37.6)
Asian 212 (14.6) 202 (15.4) 414 (15.0) 389 (9.6)
African American 339 (23.3) 313 (23.9) 652 (23.6) 1,241 (30.6)
Hispanic 326 (22.4) 271 (20.7) 597 (21.6) 899 (22.2)
Education Level , High School 201 (13.8) 217 (16.6) 418 (15.1) 807 (20.0)
High School/GED 219 (15.1) 275 (21.0) 494 (17.9) 742 (18.4)
, College
(. High School)
364 (25.1) 376 (28.7) 740 (26.8) 1,197 (29.7)
Bachelor’s Degree 303 (20.9) 237 (18.1) 540 (19.5) 631 (15.7)
Graduate Degree 366 (25.2) 205 (15.6) 571 (20.7) 651 (16.2)
BMI Mean +/2 SD 27.3+/24.0 26.9+/25.0 27.1+/24.5 29.3+/26.0
Waist Size (cm) Mean +/2 SD 96.7+/211.1 92.2+/213.6 94.6+/212.6 100.3+/215.4




Mean +/2 SD 1743.2+/22235.4 1379.6+/22405.9 1570.8+/22324.5 1270.9+/21996.8
Diabetes mellitus Normal (,100 mg/dl) 1,010 (69.5) 1,012 (77.3) 2,022 (73.2) 2,616 (64.7)
Impaired Fasting
Glucose (100–125 mg/dl)
248 (17.1) 172 (13.1) 420 (15.2) 721 (17.8)
Untreated Diabetes
(.= 126 mg/dl)
45 (3.1) 20 (1.5) 65 (2.4) 123 (3.0)
Treated Diabetes 150 (10.3) 106 (8.1) 256 (9.3) 582 (14.4)
Fasting Glucose
(mg/dL)– Calibrated
Mean +/2 SD 100.3+/227.2 94.1+/221.5 97.4+/224.9 102.5+/234.0
Hypertension Yes 589 (40.5) 536 (40.9) 1,125 (40.7) 2,053 (50.7)
Systolic Blood
Pressure (mmHg)
Mean +/2 SD 122.7+/218.1 121.9+/221.6 122.3+/219.9 126.8+/222.0
Diastolic Blood
Pressure (mmHg)
Mean +/2 SD 73.4+/29.0 67.2+/29.7 70.5+/29.8 70.7+/210.4
Use of Anti-Hypertensives Yes 532 (36.6) 474 (36.2) 1,006 (36.4) 1,838 (45.4)
Total Cholesterol (mg/dl) Mean +/2 SD 185.4+/234.0 199.3+/233.7 191.9+/234.5 191.4+/236.9
HDL Cholesterol (mg/dl) Mean +/2 SD 46.7+/212.3 58.6+/216.0 52.3+/215.3 51.3+/214.9
LDL Cholesterol (mg/dl) Mean +/2 SD 112.9+/231.4 115.9+/230.7 114.3+/231.1 113.6+/233.1
Triglycerides (mg/dl) Mean +/2 SD 132.5+/286.9 124.3+/271.9 128.6+/280.3 134.0+/285.9
Statin Use Yes 194 (13.4) 186 (14.2) 380 (13.8) 629 (15.5)
Creatinine (mg/dl) Mean +/2 SD 1.1+/20.2 0.8+/20.1 1.0+/20.2 1.0+/20.3
Interleukin-6 (IL-6)
(pg/mL)
Mean +/2 SD 1.3+/21.1 1.4+/21.1 1.4+/21.1 1.7+/21.3
Smoking Status Never 582 (40.1) 802 (61.2) 1,384 (50.1) 1,788 (44.2)
Former 730 (50.2) 392 (29.9) 1,122 (40.6) 1,712 (42.3)
Current 141 (9.7) 116 (8.9) 257 (9.3) 546 (13.5)
Pack Years Mean +/2 SD 12.2+/222.5 5.9+/213.4 9.2+/219.0 12.9+/224.1
doi:10.1371/journal.pone.0056826.t001
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years. Resting blood pressure was measured three times using the
Dinamap Monitor PRO 100 (Critikon, Tampa, FL) automated
oscillometric device, and the average of the last two measurements
was used. Hypertension was defined as systolic blood pressure
$140 mmHg, diastolic blood pressure $90 mmHg or self-
reported hypertension and current use of anti-hypertensive
medication. Presence of diabetes mellitus was based on self-
reported physician diagnosis, use of medication for hyperglycemia,
or a fasting glucose value $126 mg/dL, the latter measured by
rate reflectance spectrophotometry (Johnson & Johnson Clinical
Diagnostics, Inc., Rochester, NY). Fasting glucose between 100–
125 mg/dL was considered impaired fasting glucose. Fasting
blood samples were drawn and sent to a central laboratory for
measurement of glucose and lipids. Total cholesterol was assessed
using standard methods. Serum creatinine was measured by rate
reflectance spectrophotometry (Johnson & Johnson Clinical
Diagnostics, Inc., Rochester, NY 14650). IL-6 was measured by
ultra-sensitive ELISA (Quantikine HS Human IL-6 Immunoassay;
R&D Systems, Minneapolis, MN). C-reactive protein (CRP) was
measured using the BNII nephelometer (N High Sensitivity CRP;
Dade Behring Inc., Deerfield, IL). Insulin was determined by a
radioimmunoassay method using the Linco Human Insulin
Specific RIA Kit (Linco Research, Inc., St. Charles, MO 63304).
Of the patients with available RV measures from Exam 1
(2000–2002), there were 1969 patients with available additional
measures of spirometry (forced expiratory volume in 1 sec (FEV1),
forced vital capacity (FVC)), urine cotinine, and percent emphy-
sema measured on the lung windows of cardiac computed
tomography (CT) performed in Exam 2 (2004–2006).These
subjects (part of another ancillary study ‘‘MESA-Lung’’) were
not selected based on RV morphology or other characteristics.
Details of these measures are published [9], [10].
Statistical Analysis
Continuous variables were expressed as means and standard
deviations or ranges. Categorical variables were expressed as %.
We used survival analysis to characterize the relationship between
RV parameters at baseline (independent variables) and time to an
exam when dyspnea was reported (or death) (dependent variable).
To account for the interval censoring inherent in using the exam
questionnaires, the time variable was coded as 1 or 2 to
correspond to the time from Exam 2 to Exams 3 or 4 respectively.
Deaths were assigned to the next exam time variable (i.e. a death
between Exams 3 and 4 was coded as a death at Exam 4), to
minimize differential misclassification of time between the dyspnea
outcome and death.
Bivariate and multivariate Cox proportional hazards models
were estimated with RV parameters as continuous variables.
Potential covariates were assessed based on known associations
with ventricular size and heart disease, including demographics
and anthropometric variables, as well as variables reflecting
comorbidities and other characteristics (including systolic and
Table 2. Mean RV and LV measures stratified by gender.
Variable Male (N=1453) Female (N=1310)
RV EDM (g) 23.1+/24.4 18.9+/23.5
RV EDV (mL) 142.0+/229.7 107.8+/222.6
RV EF (%) 68.2+/26.1 72.6+/25.8
RV ESV (mL) 45.4+/214.1 29.8+/29.8
RV SV (mL) 96.5+/220.5 78.0+/216.3
LV EDM (g) 168.0+/235.6 120.8+/226.2
LV EDV (mL) 141.2+/231.7 112.8+/223.2
LV EF (%) 66.5+/27.1 71.6+/26.3
LV ESV (mL) 47.9+/217.3 32.4+/211.4
doi:10.1371/journal.pone.0056826.t002
Table 3. Cox proportional hazards models for RV measures
and time to dyspnea.
HR* 95%CI P value
Right ventricle end-diastolic
mass
Unadjusted model 1.15 1.06–1.24 ,0.001
Adjusted model{
Men 1.22 1.07–1.40 0.003
Women 0.95 0.83–1.09 0.49
Adjusted model + LV
end-diastolic mass
Men 1.33 1.15–1.54 ,0.001
Women 1.02 0.88–1.17 0.82
Right ventricle end-diastolic
volume
Unadjusted model 1.12 1.06–1.18 ,0.001
Adjusted model{
Men 1.20 1.09–1.32 ,0.001
Women 0.95 0.86–1.06 0.37
Adjusted model + LV
end-diastolic volume
Men 1.25 1.10–1.41 ,0.001
Women 0.99 0.87–1.13 0.90
Right ventricle ejection
fraction
Unadjusted model 0.96 0.90–1.02 0.17
Adjusted model{ 1.03 0.96–1.11 0.37





Unadjusted model 1.24 1.10–1.40 ,0.001
Adjusted model{
Men 1.24 1.02–1.51 0.03
Women 0.85 0.67–1.07 0.16
Adjusted model + LV
end-systolic volume
Men 1.27 1.03–1.58 0.03
Women 0.87 0.68–1.11 0.25
Right ventricle stroke volume
Unadjusted model 1.16 1.07–1.26 ,0.001
Adjusted model{
Men 1.30 1.14–1.49 ,0.001
Women 0.96 0.83–1.11 0.56
*All hazard ratios correspond to,1 SD decrement in the respective RV measure
(4 g for mass, 20 cc for volumes, 6% in RVEF).
{Adjusted model includes: age, race/ethnicity, education, body mass index,
waist size, hip size, smoking status, diastolic blood pressure, hypertension,
creatinine, and IL-6.
doi:10.1371/journal.pone.0056826.t003
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diastolic blood pressure, hypertension, diabetes mellitus, history of
venous thromboembolism, self-reported intentional exercise, use of
anti-hypertensives, aspirin, statins, lipid-lowering therapy, hor-
mone replacement therapy, HgA1c, total cholesterol, low- and
high-density lipoproteins, triglycerides, fasting glucose and insulin
levels, serum IL-6, C-reactive protein (CRP), serum creatinine).
Covariates which were measured at each exam (anthropometrics,
diabetes status, systolic and diastolic blood pressure, total
cholesterol, HDL, LDL, triglycerides, creatinine, glucose, CRP,
total intentional exercise, smoking status, hypertension, use of anti-
hypertensives, and others) were assessed as time-varying covari-
ates. We retained covariates in all of the models which changed
the coefficient of the RV parameter by .15% in any model.
Retained covariates included age, race/ethnicity, education, body
mass index, waist size, hip size, smoking status, diastolic blood
pressure, hypertension, creatinine, and IL-6. We forced education
level into the models to account for differences in socioeconomic
status, as recommended by the MESA parent study. Adjusting for
body mass index, waist size and hip size serves to index RV
measures to body size, so that additional indexing (e.g., body
surface area) was not necessary.
Additional models adjusted for all of the confounders plus the
respective LV measure. Adjustment for LV parameters was
performed to focus specifically on the RV, rather than bi-
ventricular processes. RVSV was not adjusted for LV stroke
volume (LVSV) considering the significant inter-dependence of
these measures. The LVSV is wholly dependent on the RVSV, so
it cannot be a confounder. Selected interactions between
demographics and RV parameters, and RV and LV parameters,
were assessed.
Primary analyses were performed with all participants with
complete data for covariates. Subset analyses were performed in
participants with available pulmonary measures from the MESA-
Lung Study. Sensitivity analyses were performed considering
death as a censoring point. P values,0.05 were considered
significant.
Results
MESA included 6814 participants (Figure 1). Of these, 5098
had MRI performed, of which 5004 were interpretable for the LV.
We selected 4634 scans for MESA-RV and attempted to interpret
4484, of which 4204 had interpretable RV measurements. The
slightly lower reading success rate (94%) compared to the LV in
MESA (98%) was likely attributable to the technical demands of
interpreting the very thin RV free wall. Of those participants with
interpretable RV measurements, 1352 participants were excluded
because they reported dyspnea at Exam 2 (prevalent dyspnea). An
additional 89 participants had incomplete covariate data, leaving a
total of 2763 participants in the final study sample (and
4051excluded).
Table 1 shows the characteristics of the study sample compared
to those excluded. The study sample had a mean age of 61.3610.0
years, and 52.6% were men. Almost forty percent self-identified as
Caucasian, 23.6% African-American, 21.6% Hispanic, and 15.0%
Chinese. The mean BMI was 27.164.5 kg/m2. The study sample
had slightly lower BMI, but was otherwise similar to those
excluded. Formal statistical testing is not appropriate for such
comparisons, which are descriptive rather than inferential. The
mean RV mass in the study sample was 21.164.5 g, the mean
RVEDV was 125.8631.6 mL, the mean RVESV was
38.0614.6 mL, and the mean RVSV was 87.7620.8 mL. The
mean RVEF was 70.366.4 %. All of these parameters were
adjusted for body size in the multivariate analyses, so that further
indexing (e.g., by body surface area) was unnecessary. Mean RV
and LV measurements for the final study sample, stratified by
gender, are shown in Table 2.
There were 12,659 person-years of follow-up, and the median
follow-up was 4.74 years. The 5-year cumulative incidence of the
report of dyspnea on hills or stairs was 13.6%, on level ground was
4.0%, and dyspnea causing the individual to stop was 5.6%. The
5-year risk of dyspnea of any type was 16.5%.
Lower RV mass was associated with an increased risk of
dyspnea in the unadjusted model (Table 3). For every 1 SD (4 g)
decrement in RV mass, there was a 15% increase in the risk of
dyspnea or death. After adjustment for confounders, there was a
22% increase in the risk of dyspnea or death for men, but no
association between RV mass and the risk of dyspnea or death for
women (p for interaction= 0.006). Further adjustment for LV
mass, if anything, strengthened the association in men (Table 3),
suggesting that the association was RV-specific and independent of
LV mass.
Smaller RVEDV, RVESV, and RVSV were also associated
with significantly increased risks of dyspnea in unadjusted models
(Table 3). One SD (20 mL) decrements in RV volumes were
associated with 12–24% increases in the risk of dyspnea. After
adjustment for confounders, there were 20–30% increases in the
risk of dyspnea for men, but no association between RV volumes
and the risk of dyspnea for women (p for interaction ,0.001 for
RVEDV, = 0.011 for RVESV, and =0.001 for RVSV). For men,
these associations persisted despite adjustment for confounders
and after adjustment for the respective LV volumes. RVEF was
not significantly associated with the risk of dyspnea (Table 3).
Subset analyses were performed in participants with available
spirometry, urine cotinine, and chest CT (N=1969). Participants
had a mean FEV1 of 24876728 ml, FVC of 33156967 ml, and
mean percent emphysema at a 2910 Hounsfield Unit threshold of
17.4612.0%. Mean spirometry, urine cotinine, and percent
emphysema values, stratified by gender are shown in Table 4.
Including age and body size measurements allowed the use of
absolute spirometric measures in the adjusted analyses. In this
subset, the associations of RV mass and RV volumes with the risk
Table 4. Mean spirometry, urine cotinine, and percent emphysema values, stratified by gender.
Variable Male (N=1048) Female(N=921)
FEV1 (mL) 2893.7+/2656.6 2025.2+/2490.1
FVC (mL) 3906.6+/2822.7 2641.6+/2613.1
FEV1/FVC Ratio 0.7+/20.1 0.8+/20.1
Calculated mean cotinine concentration (ng/ml) 725.6+/22731.9 436.0+/21943.8
Emphysema (%) 21.4+/212.3 12.8+/29.9
doi:10.1371/journal.pone.0056826.t004
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of dyspnea were similar to those from the full dataset (and stronger
in most cases) (Table 5). Reclassifying death as a censoring point
did not significantly affect the results (data not shown).
Discussion
We have shown that lower RV mass and smaller RV volumes in
multi-ethnic community-based men without clinical cardiovascu-
lar disease at baseline were associated with an increased risk of
developing dyspnea. While contrary to our original hypothesis,
these findings were independent of confounders. These associa-
tions remained after adjustment for spirometric measurements, %
emphysema by CT, and the respective LV parameters, suggesting
that neither lung structure and function nor LV morphology
account for the association of RV structure with the risk of
dyspnea. RV morphology may contribute to symptoms in adults
without clinical cardiovascular or pulmonary disease.
Our original hypothesis was based on what is known about RV
remodeling in response to pulmonary hypertension, which results
in RV hypertrophy and increasing RV volumes. The opposite
results found in this study may well reflect a completely separate
disease process accounting for dyspnea in these individuals free of
clinical cardiovascular disease at baseline. For example, we have
shown smaller LV volumes in those with subclinical chronic
obstructive pulmonary disease [11], and our recent studies suggest
a similar phenomenon in the RV.
We have previously shown associations between lower FEV1/
FVC ratio and greater emphysema by CT and smaller LV end-
diastolic volume and stroke volumes and lower cardiac output,
particularly among smokers [11]. Pulmonary function could
impact the RV and result in dyspnea and could certainly
confound the relationship between RV morphology and dyspnea.
Obstructive ventilatory physiology and emphysema, air trapping,
increased intrathoracic pressure, and subsequent impaired RV
filling could both shrink RV volumes and increase the risk of
dyspnea. Therefore, we included available measures of spirometry,
urine cotinine, and percent emphysema in multivariate analysis to
‘‘control’’ for lung function and emphysema. We did not find
significant changes in our conclusions based on this analysis,
suggesting that our findings are not due to differences in lung
structure or function. Others have shown that RV failure in
pulmonary hypertension is associated with reduction in LV mass
[12]. Therefore, changes in RV structure and function might lead
to dyspnea by affecting changes in LV structure. However, our
findings persisted despite adjustment for LV measures, suggesting
other explanations.
Factors affecting the intrinsic compliance or diastolic function of
the RV (therefore decreasing RV volumes) may pre-dispose to
dyspnea. We have previously demonstrated that being overweight
or obese are independently associated with differences in RV
morphology even after adjustment for the respective LV measure
[13]. However, in the present study all RV parameters were
adjusted for body size in multivariate analysis suggesting our
results were independent of body size. In addition, we (and others)
have found age-related decrements in RV mass and volumes
(implying a maladaptive process) [14], [15], [16], yet our results
were independent of age. RV diastolic dysfunction is a known risk
factor for worse outcomes in patients with established cardiovas-
cular disease [17], [18], but there are few data focused on RV
diastolic function in large multi-ethnic populations of clinical
cardiovascular disease-free adults.
There are several possible explanations for the significant
associations in men but not in women. Men and women have
different RV mass, volumes, and RVEF in disease-free individuals
[14], [15], [19]. We postulate that our findings that lower RV
mass and smaller RV volumes are associated with increased risk of
developing dyspnea represents a different pathophysiologic mech-
anism from the one that links RV hypertrophy and increased
Table 5. Cox proportional hazards models for RV measures
and time to dyspnea in participants with available lung
measures.
HR* 95%CI P value
Right ventricle end-diastolic
mass
Unadjusted model 1.12 1.02–1.24 0.01
Adjusted model{
Men 1.13 0.96–1.33 0.14
Women 0.96 0.81–1.13 0.58
Adjusted model + LV
end-diastolic mass
Men 1.20 1.01–1.44 0.04
Women 1.00 0.84–1.19 1.00
Right ventricle end-diastolic
volume
Unadjusted model 1.10 1.03–1.17 0.004
Adjusted model{
Men 1.15 1.02–1.30 0.02
Women 0.94 0.83–1.06 0.31
Adjusted model + LV
end-diastolic volume
Men 1.18 1.01–1.38 0.03
Women 0.96 0.82–1.13 0.63
Right ventricle ejection
fraction
Unadjusted model 0.93 0.86–1.01 0.06
Adjusted model{ 1.01 0.93–1.10 0.75





Unadjusted model 1.25 1.08–1.45 0.002
Adjusted model{
Men 1.29 1.01–1.64 0.04
Women 0.80 0.60–1.05 0.10
Adjusted model + LV
end-systolic volume
Men 1.33 1.02–1.73 0.03
Women 0.82 0.61–1.10 0.17
Right ventricle stroke volume
Unadjusted model 1.12 1.01–1.23 0.03
Adjusted model{
Men 1.19 1.00–1.40 0.04
Women 0.96 0.81–1.13 0.58
*All hazard ratios correspond to,1 SD decrement in the respective RV measure
(4 g for mass, 20 cc for volumes, 6% in RVEF).
{Adjusted model includes age, race/ethnicity, education, body mass index,
waist size, hip size, smoking status, diastolic blood pressure, hypertension,
creatinine, IL-6, FEV1, FVC, cotinine, percent emphysema, and CT scanner type.
doi:10.1371/journal.pone.0056826.t005
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volumes in pulmonary hypertension. Subtle RV changes could
differentially impact on the sensation of dyspnea in men and
women. Furthermore, the determination of incident dyspnea by
questionnaire might be different for men than for women. For
example, the perception of dyspnea (or response to questions)
could be sex-specific. Large population-based studies suggest that
the prevalence of breathlessness is greater in women than men
[20]. In addition, in patients with similar severity COPD [21],
asthma [22], or idiopathic pulmonary fibrosis (IPF) [23], women
experience greater dyspnea than men. These sex-specific differ-
ences in reporting of dyspnea could affect the demonstrated
associations with RV morphology. Alternatively, differences in RV
morphology in males may have distinct implications than such
differences in women. One of the strengths of MESA is the ability
to detect the impact of subclinical cardiovascular changes between
individuals of different sexes.
There are several potential limitations of this study. Participant
report of dyspnea has inherent subjectivity. Of course, any error in
the reporting of dyspnea would likely be non-differential and thus
bias towards the null, so that the actual associations of RV
structure and the onset of dyspnea may be even stronger than
shown. In addition, interval censoring from using questionnaires
administered at each face-to-face exam limited the precision in the
assessment of time to dyspnea. Such censoring should again (if
anything) bias to the null. There were a significant number of
participants not included in our analysis given that they had
dyspnea when first administered the questionnaire (Exam 2).
While exclusion of these participants may decrease generalizabil-
ity, inclusion of these individuals might lead to reverse causation.
Last, deaths were considered as end points, since the alternative
would have been to censor at death, defying the assumptions of
non-informative censoring. If misclassification resulted from
classifying all deaths as ‘‘dyspnea’’ end points (without a systematic
relation to RV morphology), this would again bias to the null.
Sensitivity analyses showed that our findings were robust to
exclusion of death as an endpoint.
In summary, we have demonstrated an association between RV
mass and volumes and the development of dyspnea in a
cardiovascular disease-free population. These findings were
independent of confounders and were not explained by differences
in pulmonary structure and function. Significant gender interac-
tions were present with associations between RV measures and
dyspnea significant only in men. These data reveal important
clinical implications of the RV in determining the risk of dyspnea
and physical limitation in cardiovascular disease-free individuals in
the community.
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